August 27, 2016 12:35 AM ET

Commercial Services and Supplies

Company Overview of Juvenile Diabetes Research Foundation International Inc.

Company Overview

Juvenile Diabetes Research Foundation International Inc. (JDRF) is a not-for-profit organization that focuses on juvenile diabetes cure research and development services. The organization offers grants for diabetes clinical trials to laboratories, educational institutions, and pharmaceutical and medical research companies. JDRF was founded in 1970 and is headquartered in New York City with an additional office in Houston, Texas.

120 Wall Street

19th Floor

New York, NY 10005-4001

United States

Founded in 1970





Key Executives for Juvenile Diabetes Research Foundation International Inc.

Chief Executive Officer, President and Director
Chief Financial Officer
Executive Vice President for Development and Chief Operating Officer
Vice President-Customer Services
Executive Vice President for Research
Compensation as of Fiscal Year 2016.

Juvenile Diabetes Research Foundation International Inc. Key Developments

Mannkind Corporation Announces Collaboration with JDRF

MannKind Corporation announced that it has entered into a collaboration agreement with JDRF (formerly known as Juvenile Diabetes Research Foundation). The collaboration will combine JDRF’s significant scientific and human resources with MannKind’s active participation in the field of diabetes research and development in order to advance new treatments and therapies in areas of strategic alignment that can transform the lives of people with diabetes. A focus of the collaboration will be on the use of Afrezza®, with its unique insulin delivery method, in the pediatric population.

Juvenile Diabetes Research Foundation International Inc. Presents at NewYork BIO Annual Conference 2016, May-12-2016 08:30 AM

Juvenile Diabetes Research Foundation International Inc. Presents at NewYork BIO Annual Conference 2016, May-12-2016 08:30 AM. Venue: New York, United States. Speakers: Michael Batten, MD, MBA, Director, Strategic Partnerships.

JDRF Announces Management Changes

JDRF announced Mark Fischer-Colbrie has been elected as the new chairman of the JDRF International Board of Directors. Mr. Fischer-Colbrie will succeed JDRF IBOD Chairman John Brady, whose two-year term ends June 30. Mark Fischer-Colbrie became involved with JDRF in 2000 after his son was diagnosed with type 1 diabetes. Mr. Fischer-Colbrie is currently the President and CEO of Labcyte Inc.

Similar Private Companies By Industry

Company Name Region
$1 Energy Fund, Inc. United States
1 Class Corp United States
1 Solution Corp United States
1-800 Junk-USA United States
100 Pablo, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Juvenile Diabetes Research Foundation International Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at